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Staphylococcus epidermidis, a commensal bacterium of healthy human skin and mucosae, can cause serious 
bloodstream infections such as bacteremia and sepsis. These infections are very hard to cure with current 
antimicrobial strategies and, thus, it is urgent to find new treatment options. To do so, the study of S. 
epidermidis virulence factors is of utmost importance. Therefore, the ex vivo human blood model has gained 
special interest because it enables the study of S. epidermidis behavior in the context of a bloodstream 
infection. However, this model presents limitations, mainly related to the availability of donors, complicating 
its implementation in the academic context. To overcome this limitation, the possibility of replacing fresh 
human blood by commercial blood from other mammals was evaluated. 
 
The survival of several S. epidermidis strains, the secretion of proteases and the level of transcription of the 
genes sepA and hld were determined after 4 hours of interaction with fresh human blood and commercial 
horse and sheep blood. The results obtained showed, in two the inocula tested (10e8 and 10e5 CFU/mL), 
that although in human blood the number of bacteria tended to decrease (4 to 6-fold) during period of 
incubation, in both horse and sheep blood a significant increase in the number of bacteria was observed (2 
to 4-fold). Furthermore, the results obtained suggested that the replacement of human blood by horse or 
sheep blood did not cause significant alterations in the secretion of proteases. Finally, the transcription level 
of the gene sepA was similar in the 3 types of blood, but the transcription of the gene hld was significantly 
different among conditions, being 5 to 50-fold more expressed in human blood than in horse and sheep blood, 
respectively. 
 
Overall, the results obtained show that depending on the parameters under analysis, fresh human blood may 
or not be replaced by commercial horse or sheep blood implicating, thus, previous evaluation of its 
substitution. 
 
This study was supported by FCT through the funded project PTDC/BIA-MOL/29553/2017, under the scope 
of COMPETE2020 (POCI-01-0145-FEDER-029553) and by the strategic funding of unit 
UID/BIO/04469/2019. 
 
 
